Hopital Maisonneuve- Rosemont; Rheumatology
Montreal, Quebec, Canada
Hospital in Montreal, Quebec
5415 Assomption Blvd, Montreal, Quebec H1T 2M4
800 Beds
About Hopital Maisonneuve- Rosemont; Rheumatology
Hôpital Maisonneuve-Rosemont is a hospital in Montreal, Quebec, Canada, located in the boroughs of Rosemont–La Petite-Patrie and Mercier-Hochelaga-Maisonneuve. It serves the eastern part of the city and offers 800 beds. It employs 5,000 people and 3,000 students annually.
There are 800 beds in Hopital Maisonneuve- Rosemont; Rheumatology.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hopital Maisonneuve- Rosemont; Rheumatology
During the past decade, Hopital Maisonneuve- Rosemont; Rheumatology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
2013-04-01
2030-01-01
Active, not recruiting
1,900
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
2013-12-13
Active, not recruiting
1,473
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
2013-12-23
2023-07-01
Active, not recruiting
488
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
2014-08-18
Recruiting
8,300
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
2014-07-22
2023-12-31
Active, not recruiting
280
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
2014-08-18
2036-05-01
Recruiting
168
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
2015-07-13
2023-10-02
Active, not recruiting
300
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Maisonneuve- Rosemont; Rheumatology"
#1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Hopital Maisonneuve- Rosemont; Rheumatology
According to Clinical.Site data, the most researched conditions in "Hopital Maisonneuve- Rosemont; Rheumatology" are
"Rheumatoid Arthritis" (2 trials). Many other conditions were trialed in "Hopital Maisonneuve- Rosemont; Rheumatology" in a lesser frequency.
Clinical Trials Intervention Types at Hopital Maisonneuve- Rosemont; Rheumatology
Most popular intervention types in "Hopital Maisonneuve- Rosemont; Rheumatology" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Methotrexate" (2 trials), "Leflunomide" (1 trials), "Ocrelizumab" (1 trials), "Placebo" (1 trials) and "Placebo to methotrexate" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hopital Maisonneuve- Rosemont; Rheumatology
The vast majority of trials in "Hopital Maisonneuve- Rosemont; Rheumatology" are
2 trials for "All" genders.
Clinical Trials Status at Hopital Maisonneuve- Rosemont; Rheumatology
Currently, there are NaN active trials in "Hopital Maisonneuve- Rosemont; Rheumatology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Hopital Maisonneuve- Rosemont; Rheumatology,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hopital Maisonneuve- Rosemont; Rheumatology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".